With work experience over four years, this expert is currently working at Otsuka Pharmaceutical Co as a Director. Haru received his education from 2004 to 2009 at the 京都府立医科大学 / Kyoto Prefectural University of Medicine. This professional can be found in Princeton, New Jersey. To contact Haru, you can search for their phone number or e-mail or get exhaustive info by requesting access to the professional's further details.
Name variants:
Haru Sugino
Last updated May 14, 2024
Contact Information
Last Update
Jul 3, 2022
Email
ha**@otsuka-us.com
Location
Princeton, NJ
Workplace

Colleagues
Work History
Global Project Coordinator
Oct 2010 — Apr 2012
Education
1995 — 1997
Occupations
Executive
Director of Business Development
Director
Coordinator
Business Development Manager
Operations Manager
Managers
Skills
Pharmaceutical Industry
Clinical Research
Cro
Cns Disorders
Gcp
Oncology
Drug Development
Clinical Development
Radioligand Binding
Safety Pharmacology
Neuropathic Pain
Neuroscience
Neurodegenerative Disease
Neuropharmacology
Biotechnology
Pharmaceutics
FAQs about Haru Sugino
What is the main profession of Haru Sugino?
Haru is a Senior Director Business Development.
What jobs is Haru proficient at at?
Haru Sugino is a professional Executive and Director of Business Development jobs.
Where does Haru Sugino currently live?
Princeton, New Jersey is the place where Haru Sugino currently lives
Does Haru Sugino have the email address?
ha**@otsuka-us.com is Haru's email address.
Where did Haru Sugino work?
Haru Sugino worked at Otsuka Pharmaceutical Co., Ltd, Otsuka pharmaceutical development and commercialization.
What education does Haru Sugino have?
Haru studied at the 京都府立医科大学 / Kyoto Prefectural University of Medicine from 2004 to 2009.
What is professional industry that Haru Sugino is connected to?
This person works in Pharmaceuticals industry.
What are the skills of Haru Sugino?
Haru Sugino has the following skills: Pharmaceutical Industry, Clinical Research, Cro, Cns Disorders, Gcp, Oncology, Drug Development, Clinical Development, and Radioligand Binding.